Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lovering, A. M.
Right arrow Articles by MacGowan, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovering, A. M.
Right arrow Articles by MacGowan, A. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 47, 483-486
© 2001 The British Society for Antimicrobial Chemotherapy


Brief report

The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone

A. M. Loveringa,*, T. R. Walsha, G. C. Bannisterb and A. P. MacGowana

a Bristol Centre for Antimicrobial Research and Evaluation (BCARE), Department of Medical Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB; b Department of Orthopaedics, Southmead Hospital, Bristol BS10 5NB, UK

Thirteen patients undergoing total hip replacement were given ceftriaxone 1 g and cefamandole 1 g simultaneously, either immediately or 8 h before surgery. For both agents the concentrations seen in the bone and fat during the operation, and for haematoma fluid <=24 h after the operation, exceeded the MIC for susceptible staphylococci and would be expected to provide adequate prophylaxis. Although ceftriaxone concentrations in bone and fat were significantly higher than those of cefamandole, after correction for the simultaneous blood concentrations, we were unable to detect any differences in the bone or fat penetration of the two agents. We conclude that there is no evidence that cephalosporins with a lower serum protein binding penetrate bone better than ones with higher serum protein binding.

* Corresponding author. Tel: +44-117-9595653; Fax: +44-117-9593217; E-mail: Lovering_a{at}southmead.swest.nhs.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
A. Khan, P. Yates, A. Lovering, G. C. Bannister, and R. F. Spencer
The effect of surgical approach on blood flow to the femoral head during resurfacing
J Bone Joint Surg Br, January 1, 2007; 89-B(1): 21 - 25.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
M. H. Scheetz, K. M. Hurt, G. A. Noskin, and C. M. Oliphant
Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens.
Am. J. Health Syst. Pharm., July 15, 2006; 63(14): 1346 - 1360.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. M. Lovering, J. Zhang, G. C. Bannister, B. J. A. Lankester, J. H. M. Brown, G. Narendra, and A. P. MacGowan
Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement
J. Antimicrob. Chemother., July 1, 2002; 50(1): 73 - 77.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Zhang and A. M. Lovering
Difficulties in the assay of cefamandole highlight the importance of specific methodologies in pharmacokinetic studies
J. Antimicrob. Chemother., July 1, 2001; 48(1): 154 - 155.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.